Streetbeat News

Revenues

EWU

The U.K. Industrial Production for August increased by 0.5%, surpassing the estimated 0.2% and improving from the revised prior figure of -0.7%.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 6:01 am

EWU

The U.K. Gross Domestic Product (GDP) for August increased by 0.2%, matching the estimated growth and improving from the previous month's 0.0% growth.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2024 | 6:01 am

PROC

Procaps Group has announced that an independent investigation has identified certain historical transactions that require the company to restate its financial statements. Additionally, the company plans to implement a long-term restructuring plan.

Portfolio Pulse from Benzinga Newsdesk

October 10, 2024 | 9:31 pm

VRT

Vertiv Holdings (NYSE:VRT) has significantly outperformed the market over the past 5 years, with an average annual return of 60.09%. A $100 investment in VRT 5 years ago would now be worth $1,050.54, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

October 10, 2024 | 9:30 pm

LHX

L3Harris Technologies (NYSE:LHX) has delivered an average annual return of 12.78% over the past 15 years, outperforming the market by 1.04% annually. A $1000 investment in LHX 15 years ago would now be worth $6,511.28, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

October 10, 2024 | 9:30 pm

CLMB

Climb Global Solutions (NASDAQ:CLMB) has received mixed analyst ratings over the past three months, with a current average 12-month price target of $84.5. The company has shown strong financial performance, including a 12.66% revenue growth rate and impressive profitability metrics.

Portfolio Pulse from Benzinga Insights

October 10, 2024 | 9:01 pm

BIIB

Biogen (NASDAQ:BIIB) has received mixed analyst ratings over the past three months, with a recent decline in the average 12-month price target. Analysts have adjusted their ratings and price targets, reflecting changing market conditions and company performance. Biogen's financials show strong profitability and effective cost management, but its revenue growth lags behind industry peers.

Portfolio Pulse from Benzinga Insights

October 10, 2024 | 9:01 pm

WPC

W.P. Carey (NYSE:WPC) has been analyzed by 8 analysts, showing a range of sentiments from bullish to bearish. The average 12-month price target is $61.88, with a high of $66.00 and a low of $56.00. Recent analyst actions include both raises and lowers in ratings and price targets. W.P. Carey faces revenue challenges but maintains strong net margins and effective debt management.

Portfolio Pulse from Benzinga Insights

October 10, 2024 | 9:00 pm

RGA

Reinsurance Group of America Inc (NYSE:RGA) has received varied analyst ratings over the past three months, with a majority being somewhat bullish. The average 12-month price target has increased by 5.26% to $240. Analysts have adjusted their ratings and price targets, reflecting positive sentiment and expectations for RGA's future performance. The company has shown strong revenue growth and profitability, though it faces challenges in debt management.

Portfolio Pulse from Benzinga Insights

October 10, 2024 | 9:00 pm

BIRK

Birkenstock Holding (NYSE:BIRK) has been analyzed by 9 financial analysts, showing a range of sentiments from bullish to somewhat bullish. Analysts have set a 12-month average price target of $68.0, with a high of $77.00 and a low of $60.00. The company's recent financial performance includes a 19.35% revenue growth rate and a net margin of 13.22%, both above industry averages. However, its return on equity is below industry benchmarks.

Portfolio Pulse from Benzinga Insights

October 10, 2024 | 9:00 pm